Page 137
P. 137
La eliminación de los ácidos grasos trans artificiales en Argentina: los efectos
estimados sobre la carga de las enfermedades coronarias y sus costos
rios. Buenos Aires: Ministerio de Salud; 2008.
Español.
38. Murray CJ, Acharya AK. Understanding
AVADs (disability-adjusted life years). J Health
Econ. 1997 Dec;16(6):703–30. doi: http://dx.doi.
org/10.1016/S0167-6296(97)00004-0 PMID:
10176780
39. Health statistics and information systems.
Geneva: World Health Organization; 2015.
Available from: http://www.who.int/healthinfo/
global_burden_disease/tools_software/en/ [cited
2014 March 10].
40. Briggs AH, Weinstein MC, Fenwick EA,
Karnon J, Sculpher MJ, Paltiel AD; ISPOR-
SMDM Modeling Good Research Practices
Task Force. Model parameter estimation and
uncertainty analysis: a report of the ISPOR-
SMDM Modeling Good Research Practices Task
Force Working Group-6. Med Decis Making.
2012 Sep-Oct;32(5):722–32. doi: http://dx.doi.
org/10.1177/0272989X12458348 PMID:
22990087
41. Astrup A. The Trans fatty acid story in Den-
mark. Atheroscler Suppl. 2006 May;7(2):43–6.
doi: http://dx.doi.org/10.1016/j.atherosclerosis-
sup.2006.04.010 PMID: 16723283
42. O’Keeffe C, Kabir Z, O’Flaherty M, Walton J,
Capewell S, Perry IJ. Modelling the impact of
specific food policy options on coronary heart
disease and stroke deaths in Ireland. BMJ Open.
2013;3(7):e002837. PMID: 23824313
43. Downs SM, Thow AM, Leeder SR. The effecti-
veness of policies for reducing dietary Trans fat:
a systematic review of the evidence. Bull World
Health Organ. 2013 Apr 1;91(4):262–9H. doi:
http://dx.doi.org/10.2471/BLT.12.111468 PMID:
23599549
44. World Economic Forum, World Health Orga-
nization. From burden to “best buys”: reducing
the economic impact of non-communicable
diseases in low- and middle-income countries.
Geneva: World Economic Forum; 2011. Availa-
ble from: http://www.who.int/nmh/publications/
best_buys_summary.pdf [cited 2015 April 16].
45. Downs SM, Thow AM, Ghosh-Jerath S,
McNab J, Reddy KS, Leeder SR. From Den-
mark to Delhi: the multisectoral challenge of
regulating Trans fats in India. Public Health
Nutr. 2013 Dec;16(12):2273–80. doi: http://
dx.doi.org/10.1017/S1368980012004995 PMID:
23164094
46. Barton P, Andronis L, Briggs A, McPherson K,
Capewell S. Effectiveness and cost effectiveness
of cardiovascular disease prevention in whole
populations: modelling study. BMJ. 2011;343
jul28 1:d4044. doi: http://dx.doi.org/10.1136/
bmj.d4044 PMID: 21798967
47. O’Keeffe C, Kabir Z, O’Flaherty M, Walton J,
Capewell S, Perry IJ. Modelling the impact of
specific food policy options on coronary heart
disease and stroke deaths in Ireland. BMJ Open.
2013;3(7):e002837. PMID: 23824313
48. de Fatima Marinho de Souza M, Gawrys-
zewski VP, Orduñez P, Sanhueza A, Espinal
MA. Cardiovascular disease mortality in the
Americas: current trends and disparities. Heart.
2012 Aug;98(16):1207–12. doi: http://dx.doi.
org/10.1136/heartjnl-2012-301828 n
A&G 102 • Tomo XXVI • Vol. 1 • 120-129 • (2016) 129
estimados sobre la carga de las enfermedades coronarias y sus costos
rios. Buenos Aires: Ministerio de Salud; 2008.
Español.
38. Murray CJ, Acharya AK. Understanding
AVADs (disability-adjusted life years). J Health
Econ. 1997 Dec;16(6):703–30. doi: http://dx.doi.
org/10.1016/S0167-6296(97)00004-0 PMID:
10176780
39. Health statistics and information systems.
Geneva: World Health Organization; 2015.
Available from: http://www.who.int/healthinfo/
global_burden_disease/tools_software/en/ [cited
2014 March 10].
40. Briggs AH, Weinstein MC, Fenwick EA,
Karnon J, Sculpher MJ, Paltiel AD; ISPOR-
SMDM Modeling Good Research Practices
Task Force. Model parameter estimation and
uncertainty analysis: a report of the ISPOR-
SMDM Modeling Good Research Practices Task
Force Working Group-6. Med Decis Making.
2012 Sep-Oct;32(5):722–32. doi: http://dx.doi.
org/10.1177/0272989X12458348 PMID:
22990087
41. Astrup A. The Trans fatty acid story in Den-
mark. Atheroscler Suppl. 2006 May;7(2):43–6.
doi: http://dx.doi.org/10.1016/j.atherosclerosis-
sup.2006.04.010 PMID: 16723283
42. O’Keeffe C, Kabir Z, O’Flaherty M, Walton J,
Capewell S, Perry IJ. Modelling the impact of
specific food policy options on coronary heart
disease and stroke deaths in Ireland. BMJ Open.
2013;3(7):e002837. PMID: 23824313
43. Downs SM, Thow AM, Leeder SR. The effecti-
veness of policies for reducing dietary Trans fat:
a systematic review of the evidence. Bull World
Health Organ. 2013 Apr 1;91(4):262–9H. doi:
http://dx.doi.org/10.2471/BLT.12.111468 PMID:
23599549
44. World Economic Forum, World Health Orga-
nization. From burden to “best buys”: reducing
the economic impact of non-communicable
diseases in low- and middle-income countries.
Geneva: World Economic Forum; 2011. Availa-
ble from: http://www.who.int/nmh/publications/
best_buys_summary.pdf [cited 2015 April 16].
45. Downs SM, Thow AM, Ghosh-Jerath S,
McNab J, Reddy KS, Leeder SR. From Den-
mark to Delhi: the multisectoral challenge of
regulating Trans fats in India. Public Health
Nutr. 2013 Dec;16(12):2273–80. doi: http://
dx.doi.org/10.1017/S1368980012004995 PMID:
23164094
46. Barton P, Andronis L, Briggs A, McPherson K,
Capewell S. Effectiveness and cost effectiveness
of cardiovascular disease prevention in whole
populations: modelling study. BMJ. 2011;343
jul28 1:d4044. doi: http://dx.doi.org/10.1136/
bmj.d4044 PMID: 21798967
47. O’Keeffe C, Kabir Z, O’Flaherty M, Walton J,
Capewell S, Perry IJ. Modelling the impact of
specific food policy options on coronary heart
disease and stroke deaths in Ireland. BMJ Open.
2013;3(7):e002837. PMID: 23824313
48. de Fatima Marinho de Souza M, Gawrys-
zewski VP, Orduñez P, Sanhueza A, Espinal
MA. Cardiovascular disease mortality in the
Americas: current trends and disparities. Heart.
2012 Aug;98(16):1207–12. doi: http://dx.doi.
org/10.1136/heartjnl-2012-301828 n
A&G 102 • Tomo XXVI • Vol. 1 • 120-129 • (2016) 129
